Literature DB >> 9043843

The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure.

S D Anker1, J W Swan, M Volterrani, T P Chua, A L Clark, P A Poole-Wilson, A J Coats.   

Abstract

BACKGROUND: The influence of age, skeletal muscle function and peripheral blood flow on exercise capacity in chronic heart failure patients is controversial, possibly due to variations in skeletal muscle atrophy. METHODS AND
RESULTS: To assess predictors of exercise capacity in patients with clinical cardiac cachexia, we studied 16 cachectic and 39 non-cachectic male chronic heart failure patients of similar age and ejection fraction. All cachectic patients were wasted (% ideal body weight: 81.2 +/- 1.9 vs 105.2 +/- 2.1, P < 0.0001, mean +/- SEM) and had documented weight loss (5-30 kg). Peak oxygen consumption (14.9 +/- 1.4 vs 16.3 +/- 0.6 ml.kg-1, min-1, resting and peak blood flow (plethysmography) and 20 min fatigability (% baseline strength) were all similar between the two groups. Quadriceps strength, muscle size (all P < 0.0001), strength per unit muscle (right: P < 0.05: left: P < 0.001) and 5 min fatigability (P < 0.05) were all lower in cachectic patients. In non-cachectic patients, age (R = 0.48) and quadriceps strength (R = 0.43, all P < 0.01) predicted peak oxygen consumption. Only in cachectic patients did peak blood flow predict peak oxygen consumption significantly (R = 0.72, P = 0.005), whereas age and strength did not. Similar findings were confirmed using other previously published definitions of cardiac cachexia.
CONCLUSIONS: The predictors of exercise capacity change with the development of cardiac cachexia from age and strength to peak blood flow. This shift may be caused by additional endocrine or catabolic, abnormalities active in end stage heart failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9043843     DOI: 10.1093/oxfordjournals.eurheartj.a015229

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  32 in total

1.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes.

Authors:  G Vescovo; M Volterrani; R Zennaro; M Sandri; C Ceconi; R Lorusso; R Ferrari; G B Ambrosio; L Dalla Libera
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

Review 3.  The role of exercise training in chronic heart failure.

Authors:  R P Wielenga; A J Coats; W L Mosterd; I A Huisveld
Journal:  Heart       Date:  1997-11       Impact factor: 5.994

Review 4.  Effects of exercise training on neurovascular control and skeletal myopathy in systolic heart failure.

Authors:  Carlos E Negrao; Holly R Middlekauff; Igor L Gomes-Santos; Ligia M Antunes-Correa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-02-13       Impact factor: 4.733

Review 5.  Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications.

Authors:  A P Bolger; S D Anker
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

6.  Adiposity facilitates increased strength capacity in heart failure patients with reduced ejection fraction.

Authors:  Alexandra Zavin; Karla Daniels; Ross Arena; Kelly Allsup; Antonio Lazzari; Jacob Joseph; P Christian Schulze; Stewart H Lecker; Daniel E Forman
Journal:  Int J Cardiol       Date:  2012-06-27       Impact factor: 4.164

Review 7.  The obesity paradox in chronic heart failure: what does it mean?

Authors:  Paul J Chase; Paul G Davis; Daniel R Bensimhon
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 8.  Update on melanocortin interventions for cachexia: progress toward clinical application.

Authors:  Mark Daniel DeBoer
Journal:  Nutrition       Date:  2009-12-08       Impact factor: 4.008

9.  Comparison of skeletal muscle strength between cardiac patients and age-matched healthy controls.

Authors:  K Baum; U Hildebrandt; K Edel; R Bertram; H Hahmann; F J Bremer; S Böhmen; C Kammerlander; M Serafin; Th Rüther; E Miche
Journal:  Int J Med Sci       Date:  2009-07-06       Impact factor: 3.738

10.  Chronic heart failure and exercise intolerance: the hemodynamic paradox.

Authors:  Kent R Nilsson; Brian D Duscha; Patrick M Hranitzky; William E Kraus
Journal:  Curr Cardiol Rev       Date:  2008-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.